| Issue |
Title |
File |
| No 1 (2016) |
EVALUATION OF THE PSYCHONEUROLOGICAL STATUS OF INFANTS WITH INTRAUTERINE GROWTH RETARDATION IN NEONATOLOGICAL PRACTICE |
|
|
Kirillova E.A., Ushakova L.V., Bychenko V.G.
|
| No 5 (2015) |
EVALUATION OF UTERINE-PLACENTAL-FETAL BLOOD FLOW AND PLACENTAL MORPHOLOGICAL FEATURES IN PLACENTAL ABRUPTION |
|
|
Komilova M.S., Pakhomova J.E.
|
| No 10 (2017) |
Evgeniy A. Chernukha |
|
|
- -.
|
| No 4 (2016) |
Evidence-based medicine and a model for an algorithm to choose the best hormonal contraceptive |
|
|
Rukhlyada N.N.
|
| No 6 (2014) |
EVIDENCE-BASED MEDICINE PRINCIPLES IN THE DIAGNOSIS AND PREVENTION OF PYOINFLAMMATORY THROMBOEMBOLIC EVENTS IN PUERPERAS: RESULTS OF INTRODUCTION OF NEW PROTOCOLS |
|
|
SHMAKOV R.G., KARIMOVA G.N., POLUSHKINA E.S., PHILIPPOVICH G.V., PYREGOV A.V., TYUTYUNNIK V.L.
|
| No 6 (2009) |
Evolution and perspectives of bulk-forming agents in the treatment of stress urinary incontinence |
|
|
Saidova A.S., Apolikhina I.A., Zheleznyakova A.I.
|
| No 6 (2013) |
EVOLUTION OF HEPARIN USE IN OBSTETRIC CARE |
|
|
KIRYUSHCHENKOV P.A., KOVALEV M.V., TAMBOVTSEVA M.A.
|
| No 2 (2013) |
EVOLUTION OF IDEAS ON THROMBOPHILIA AND ITS ROLE IN HUMAN REPRODUCTION PROBLEMS |
|
|
MOMOT A.P., TARANENKO I.A., TSYVKINA L.P.
|
| No 3 (2023) |
Evolution of nerve-sparing radical hysterectomy: a historical flashback and technical features |
|
|
Dymova A.V., Davydova I.Y., Valiev R.K., Nurberdyev M.B., Ivanova L.B., Saryev M.N., Loginova E.A., Tizilova E.A.
|
| No 6 (2018) |
Evolution of the goals of menopausal hormone therapy. From treatment for hot flushes to the new horizons of cardiometabolic protection |
|
|
Yureneva S.V., Dubrovina A.V.
|
| No 4 (2023) |
Excess adipose tissue and chronic subclinical inflammation in patients with polycystic ovary syndrome |
|
|
Kirillova E.D., Krechetova L.V., Vtorushina V.V., Ivanets T.Y., Chernukha G.E.
|
| No 5 (2016) |
EXCESSIVE WEIGHT GAIN DURING PREGNANCY: OBSTETRICAL ASPECTS |
|
|
Pokusaeva V.N., Vakhrushina A.S., Marinovicheva E.I., Stepankova E.A., Shalkina L.A., Nikiforovsky N.K.
|
| No 2 (2021) |
EXOGENOUS CYTOKINE THERAPY IN THE TREATMENT OF PATIENTS WITH CHRONIC ENDOMETRITIS |
|
|
Dobrokhotova Y.E., Gankovskaya L.V., Borovkova E.I., Nugumanova O.R.
|
| No 12 (2021) |
Exome sequencing for diagnosing and predicting uterine and vaginal anomalies |
|
|
Arakelyan A.S., Shubina J., Popryadukhin A.Y., Goltsov A.Y., Trofimov D.Y., Adamyan L.V.
|
| No 1 (2019) |
Experience in managing pregnant women at high risk for preterm birth, by using a dome-shaped obstetric pessary and cerclage |
|
|
Barinov S.V., Artymuk N.V., Novikova O.N., Shamina I.V., Tirskaya Y.I., Belinina A.A., Lazareva O.V., Kadtsyna T.V., Frikel E.A., Atamanenko O.Y., Ostrovskaya O.V., Stepanov S.S., Beglov D.E.
|
| No 4 (2008) |
Experience in pathogenetically correcting blood coagulative disorders during laparoscopic gynecological operations |
|
|
Polyakova V.A., Bysbevsky A.S., Vinokurova Y.A., Chernova A.L., Baklayeva N.B., Karpova I.A., Rudzevich A.Y., Nedorizanyuk M.A.
|
| No 3 (2020) |
Experience in preparing obese patients for infertility treatment |
|
|
Zhuk T.V., Yavorskaya S.D., Vostrikov V.V., Nagaitsev V.M., Kotov A.O.
|
| No 4 (2020) |
Experience in random-start ovarian stimulation for preserving reproductive material of cancer patients |
|
|
Nazarenko T.A., Martirosyan Y.O., Biryukova A.M., Dzhanashvili L.G., Ivanets T.Y., Sukhova Y.V.
|
| No 9 (2019) |
Experience in the application of vaginal polydioxanone thread in miniperineoplasty for the treatment of the vaginal wall prolapse |
|
|
Bakhtiyarov K.R., Shchukina A.S., Kalseidova K.S.
|
| No 8 (2023) |
Experience in the clinical use of a non-hormonal vaginal cream for the treatment of genitourinary syndrome of menopause/vulvovaginal atrophy in patients with a history of estrogen-dependent oncological diseases |
|
|
Ermakova E.I., Smetnik A.A.
|
| No 11 (2021) |
Experience in the use of low-dosed levonorgestrel-containing intrauterine system LCS16 and combined oral contraceptive containing 30 mcg ethinyl estradiol and 3 mg drospirenone in young women |
|
|
Suturina L.V., Dikke G.B.
|
| No 11 (2016) |
EXPERIENCE IN TREATING BACTERIAL VAGINOSIS ASSOCIATED WITH VULVOVAGINAL CANDIDIASIS |
|
|
Zakharova T.V., Volkov V.G.
|
| No 10 (2018) |
Experience in treating early toxicosis of pregnancy |
|
|
Slizovsky G.V., Kuzhelivsky I.I., Shikunova Y.V., Sigareva Y.A.
|
| No 10 (2020) |
Experience in ultrasound detection of placental separation |
|
|
Mudrov V.A.
|
| No 2 (2013) |
EXPERIENCE IN USING A GLYCYRRHIZIC ACID PREPARATION IN YOUNG WOMEN WITH PERSISTENT PAPILLOMAVIRUS INFECTION |
|
|
SHARGORODSKAYA A.V., LESHKINA G.V., SHIPULINA O.Y., LOPATINA T.V., ROGOVSKAYA S.I.
|
| No 2 (2020) |
Experience in using a vitamin and mineral supplement to restore the menstrual cycle in patients with functional hyperprolactinemia |
|
|
Manukhina E.I., Ispas A.A.
|
| No 12 (2021) |
Experience in using ERA-test for diagnosis of endometrial receptivity in frozen embryo transfers in patients with endometriosis |
|
|
Maeva N.K., Khabarov S.V.
|
| No 8-1 (2012) |
EXPERIENCE IN USING GONADOTROPIN-RELEASING HORMONE AGONISTS IN PATIENTS WITH MULTIPLE LEIMYOMATOUS HAMARTOMA OF THE LUNG (A clinical observation) |
|
|
KAYUKOVA S.I., KOGAN E.A., CHERNUKHA G.E., FAIZULLINA N.M.
|
| No 1 (2019) |
Experience of anti-relapse therapy for ovarian endometriosis |
|
|
Levakov S.A., Budanov P.V., Gromova T.A., Yurova M.V.
|
| No 6 (2019) |
Experience of application metocinium iodide in pregnant women |
|
|
Krasilnikova A.K., Borzova N.Y., Panova I.A., Malyshkina D.A.
|
| No 9 (2019) |
Experience of application of activated glycyrrhizic acid.in vulvovaginitis, cervicitis, and genital papillomavirus infection |
|
|
Rakhmatulina M.R., Bolshenko N.V., Lipova E.V.
|
| No 11 (2023) |
Experience of clinical application of the vapigel prebiotic in combined two-stage therapy of bacterial vaginosis in reproductive-aged women |
|
|
Belyakina I.V., Galkina I.S., Shobolov D.L., Shtykunova E.V., Arantseva D.A.
|
| No 5 (2024) |
Experience of laparoscopic transabdominal cerclage for correcting cervical incompetence |
|
|
Ldynina T.Y., Pogodin O.O., Ivshin A.A., Shakurova E.Y.
|
| No 9 (2023) |
Experience of metroplasty in the second trimester in women with incompetent uterine scar |
|
|
Sukhanov A.A., Legalova T.V., Obryadov M.A., Dikke G.B., Kukarskaya I.I.
|
| No 7 (2018) |
Experience of prolonged use of dienogest in the treatment of endometriosis |
|
|
Olina A.A., Meteleva T.A.
|
| No 7-1 (2011) |
EXPERIENCE OF THE INTENSIVE CARE UNIT OF THE TYUMEN REGIONAL PERINATAL CENTER |
|
|
KUKARSKAYA I.I.
|
| No 10 (2017) |
Experience of therapy for bacterial vaginosis |
|
|
Lavrova L.V., Dyagileva N.I., Karpova E.E.
|
| No 3 (2024) |
Experience of treating patients with abnormal uterine bleeding associated with ovulatory dysfunction |
|
|
Dikke G.B., Novichkov D.A., Zulkarneeva E.M., Amirova K.Z., Beraya A.E., Gartleb O.A., Cherezova Y.M., Akhmetgaliev A.R.
|
| No 6 (2024) |
Experience of using a combined melatonin-containing drug in the correction of sleep disorders in women |
|
|
Stenyaeva N.N., Khritinin D.F., Stenyaev E.Y.
|
| No 3 (2019) |
Experience of using a double balloon catheter for cervical ripening in the induction of labor |
|
|
Baev O.R., Babich D.A., Shmakov R.G., Polushkina E.S., Nikolaeva A.V.
|
| No 10 (2022) |
Experience of using high-throughput sequencing (NGS) for noninvasive prenatal screening of fetal aneuploidy at the D.O. Ott Research Institute of Obstetrics, Gynecology and Reproduction |
|
|
Tarasenko O.A., Vashukova E.S., Kozyulina P.Y., Morshneva A.V., Maltseva A.R., Pachulia O.V., Talantova O.E., Koroteev A.L., Ivashchenko T.E., Bespalova O.N., Kogan I.Y., Baranov V.S., Glotov A.S.
|
| No 3 (2018) |
Experience of using the immunomodulator in the therapy of papillomavirus infection of genitalia in women |
|
|
Borovikov I.O., Kutsenko I.I., Gorring C.I.
|
| No 10 (2023) |
Experience of using vaginal autoprobiotics in a patient with spontaneous triplet pregnancy with recurrent vaginal anaerobic dysbiosis |
|
|
Barinova V.V., Bushtyreva I.O., Kuznetsova N.B., Suvorov A.N., Botasheva T.L.
|
| No 7-1 (2011) |
EXPERIENCE TREATING UROGENITAL CANDIDIASIS |
|
|
OLINICHENKO S.A.
|
| No 2 (2020) |
Experience with a combination drug containing ternidazole in the treatment of bacterial vaginosis |
|
|
Ulyanova I.O., Makarenko T.A., Kuznetsova D.E.
|
| No 4 (2016) |
Experience with a drug containing isoflavones used in the correction of psychosomatic disorders in women with climacteric syndrome |
|
|
Chernichenko I.I., Voishnarovich A.V.
|
| No 6 (2023) |
Experience with a modified molded sorbent in the treatment of postpartum endometritis |
|
|
Barinov S.V., Lazareva O.V., Tirskaya Y.I., Kadtsyna T.V., Chulovsky Y.I., Orlitskaya A.D., Leont’eva N.N., Blauman E.S.
|
| No 3 (2017) |
Experience with a V-Loc 180 retaining self-locking suture during laparoscopic myomectomy |
|
|
Chuprynin V.D., Khilkevich E.G., Yazykova O.I., Usacheva V.V., Melnikov M.V., Veredchenko A.V., Burykina P.N., Chursin V.V.
|
| No 6 (2014) |
EXPERIENCE WITH ALLOKIN-ALPHA IN THE TREATMENT OF HUMAN PAPILLOMAVIRUS-ASSOCIATED DISEASES |
|
|
DOVLETKHANOVA E.R., PRILEPSKAYA V.N., ABAKAROVA P.R., MEZHEVITINOVA E.A.
|
| No 4 (2008) |
Experience with an Elton Lake therapeutic mud lipid fraction used in the complex treatment of cervicitis |
|
|
Zharkin N.A., Shchetinina T.A.
|
| No 5 (2023) |
Experience with bovhyaluronidase azoximer used in the combination treatment of chronic endometritis in women with repeated implantation failures |
|
|
Lokshin V.N., Askar Y., Rybina A.N., Abshekenova A.T., Karibayeva S.K., Valiev R.K.
|
| No 7 (2015) |
Experience with carbetocin for preventing hypotonic hemorrhage |
|
|
Kurtser M.A., Kutakova J.J., Spiridonova E.I., Cherepnina A.L., Balitsky S.P.
|
| No 11 (2020) |
Experience with clotrimazole 2% cream in the therapy of vulvovaginal candidiasis: results of observational study |
|
|
Rakhmatulina M.R., Tarasenko E.N., Bolshenko N.V.
|
| No 8 (2011) |
EXPERIENCE WITH COMBINATION TREATMENT FOR GENITAL HERPES IN WOMEN |
|
|
UDZHUKHU V.Y.
|
| No 5 (2016) |
EXPERIENCE WITH COMBINATION VAGINAL AGENTS USED IN THE TREATMENT OF MIXED VAGINOSIS/VAGINITIS IN POSTMENOPAUSAL WOMEN |
|
|
Aivazova D.S.
|
| No 2 (2019) |
Experience with different cholecalciferol dosing regimens to achieve adequate levels in patients with reproductive dysfunction |
|
|
Chikh E.V., Tikhomirov S.V., Zaitseva T.A., Segedina E.M., Treivish L.S.
|
| No 2 (2012) |
EXPERIENCE WITH EFFERENT METHODS USED IN THE TREATMENT OF SEVERE HYPERLIPIDEMIA IN A PREGNANT WOMAN |
|
|
FEDOROVA T.A., ROGACHEVSKY O.V., ORDZHONIKIDZE N.V., TKACHEVA O.N., MITRYA I.V.
|
| No 4 (2008) |
Experience with focused ultrasound ablation used in uterine leiomyoma |
|
|
Sukhikh G.T., Samoilova T.Y., Maksutova D.Z., Kurinov S.B., Kulabukhova Y.A., Smetnik V.P., Volobayev A.I.
|
| No 5 (2012) |
EXPERIENCE WITH GANCICLOVIR IN THE TREATMENT OF THE GENERALIZED FORM OF CYTOMEGALOVIRUS INFECTION |
|
|
DEGTYAREVA A.V., ZUBKOV V.V., NEPSHA O.S., BURMENSKAYA O.V., LACHINYAN V.L., DONNIKOV A.E., MILAYA O.V., DEGTYAREV D.N.
|
| No 7 (2022) |
EXPERIENCE WITH GINGER IN THE TREATMENT OF NAUSEA AND VOMITING OF PREGNANCY |
|
|
KHABAROV S.V.
|
| No 12 (2013) |
EXPERIENCE WITH GLYCYRRIZIC ACID USED IN BENIGN CHANGES IN THE CERVIX UTERI |
|
|
TKACHENKO L.V., KRAPIVINA M.A.
|
| No 12 (2014) |
Experience with gynestril in the treatment of patients with uterine myoma |
|
|
Levakov S.A., Kedrova A.G., Nechaeva O.E., Vanke N.S., Chelnokova N.N., Levakova S.E.
|
| No 9 (2013) |
EXPERIENCE WITH HAEMONETICS CELL SAVER 5+ IN OBSTERIC PRACTICE |
|
|
SAVELYEVA G.M., KURTSER M.A., BRESLAV I.Y., BREUSENKO L.E., LATYSHKEVICH O.A., SHABNITSKY A.M.
|
| No 2 (2017) |
Experience with indole-3-carbinol used to treat diseases of the breast and to prevent breast cancer |
|
|
Smetnik A.A., Smetnik V.P., Kiselev V.I.
|
| No 12 (2018) |
Experience with interferon-gamma in the therapy of sexually transmitted viral infections |
|
|
Rakhmatulina M.R., Bolshenko N.V.
|
| No 11 (2021) |
Experience with Intralipid in early reproductive losses |
|
|
Bespalova O.N., Zhernakova T.S.
|
| No 11 (2020) |
Experience with intrauterine plateletrich plasma infusions for endometrial preparation in thawed embryo transfer programs in patients with an unfavorable prognosis of treatment outcomes |
|
|
Savina V.A., Samoilovich Y.A., Isakova E.V.
|
| No 8 (2013) |
EXPERIENCE WITH INVASIVE CORRECTION OF FETOFETAL TRANSFUSION SYNDROME |
|
|
KOSOVTSOVA N.V., BASHMAKOVA N.V., KOVALEV V.V., MARKOVA T.V., POTAPOV N.N.
|
| No 12 (2019) |
Experience with laser Doppler flowmetry in the evaluation of hemodynamic disorders of microcirculation in the fetoplacental complex |
|
|
Gadzhieva P.K., Dikareva L.V.
|
| No 7 (2021) |
Experience with micronized progesterone in obstetric practice |
|
|
Khodzhaeva Z.S., Klimenchenko N.I., Muminova K.T., Gorina K.A., Frankevich V.E.
|
| No 5 (2015) |
EXPERIENCE WITH MICRONIZED PROGESTERONE THERAPY FOR MISCARRIAGE IN PREGNANT WOMEN WITH UTERINE MYOMA |
|
|
Iashchuk A.G., Dautova L.A., Shevchenko Y.R., Naftulovich R.A., Tyurina A.A., Murzin V.R.
|
| No 9 (2014) |
Experience with micronized progesterone used in combined hormone therapy in periand postmenopausal women |
|
|
Yarmolinskaya M.I.
|
| No 8 (2011) |
EXPERIENCE WITH ORGAN-SPARING SURGERY FOR PLACENTA ACCRETA |
|
|
KURTSER M.A., BRESLAV I.Y., LUKASHINA M.V., SHTABNITSKY A.M., PANIN A.V., ALEKSEYEVA T.V., PLATITSIN I.V.
|
| No 6 (2016) |
Experience with oxytocin receptor antagonist for incipient preterm labor |
|
|
Fatkullin I.F., Fatkullin F.I., Munavirova A.A., Islamova L.H., Akhmetgaliev A.R., Shaikhetdinova A.T.
|
| No 4-2 (2012) |
EXPERIENCE WITH PREGNANCY AND CHILDBIRTH MANAGEMENT IN PATIENTS WITH INFLUENZA A (H1N1) |
|
|
KURTSER M.A., KALINOVSKAYA I.I., MALYSHEV N.A., SEROBYAN A.G., KELLI E.I., KUTAKOVA Y.Y., CHEREPNINA A.L.
|
| No 9 (2018) |
Experience with sanitary products containing the probiotic strain Lactobacillus acidophilus in reproductive-aged and postmenopausal women for the prevention of opportunistic vaginal infections |
|
|
Lyubasovskaya L.A., Melkumyan A.R., Dubodelov D.V., Rodchenko Y.V., Muravyeva V.V., Kondrakhin A.P., Maikova G.B., Amirkhanyan A.S., Nikolaeva N.V., Bairamova G.R., Priputnevich T.V.
|
| No 5 (2012) |
EXPERIENCE WITH SPONTANEOUS DELIVERY IN WOMEN WITH A UTERINE SCAR AFTER MYOMECTOMY |
|
|
PEKAREV O.G., MAIBORODIN I.V., PEKAREVA E.O., POZDNYAKOV I.M., POPOVA S.P.
|
| No 2 (2023) |
Experience with surgery for adenomyosis and assessment of reproductive outcomes |
|
|
Bezhenar V.F., Krylov K.Y., Makarenko T.A., Matukhin V.I., Rukhliada N.N., Tskhay V.B.
|
| No 7 (2013) |
EXPERIENCE WITH TEMPORARY BALLOON OCCLUSION OF THE COMMON ILIAC ARTERIES IN PATIENTS WITH PLACENTA INCRETA DURING ORGAN-SPARING OPERATIONS |
|
|
KURTSER M.A., BRESLAV I.Y., GRIGORYAN A.M., LATYSHKEVICH O.A.
|
| No 9 (2021) |
Experience with the natural non-hormonal drug Serelis in the therapy of menopausal syndrome in surgical menopausal women |
|
|
Gavrilov M.V., Puchkina G.A., Ermolenko N.S., Simacheva S.A., Sulima A.N.
|
| No 6 (2021) |
Experience with the vitamin-mineral complex “Pregnomama” in women with physiological pregnancy |
|
|
Gromova O.A., Pesegova E.V., Torshin I.Y., Tetruashvili N.K.
|
| No 3 (2016) |
EXPERIENCE WITH ULIPRISTAL ACETATE IN PATIENTS WITH UTERINE MYOMA |
|
|
Podzolkova N.M., Puchkov K.V., Korennaya V.V.
|
| No 11 (2020) |
Experience with ultrasonic cavitation in patients with chronic endometritis before IVF |
|
|
Khabarov S.V., Gorskaya O.S., Rusanova G.P.
|
| No 3 (2018) |
Experience with uterine balloon tamponade in postpartum hypotonic bleedings |
|
|
Askerov A.A., Nazaralieva S.B., Osmonova S.K.
|
| No 7 (2016) |
Experience with vaginal and uterine catheters Zhukovskiy and a topical hemostatic agent in the treatment of postpartum bleeding during cesarean section |
|
|
Barinov S.V., Zhukovskiy Y.G., Medyannikova I.V., Shavkun I.A., Zhilin A.V., Razdobedina I.N., Grebenyuk O.A., Kovaleva Y.A.
|
| No 5 (2016) |
EXPERIMENTAL RATIONALE FOR THE ENDOTHELIAL PROTECTIVE EFFECT OF INTRAVENOUS IMMUNOGLOBULINS IN OBSTETRIC DISEASE |
|
|
Chepanov S.V., Sokolov D.I., Shlachtenko T.N., Kapustin R.V., Okorokova L.S., Belyakova K.L., Selkov S.A.
|
| No 8 (2016) |
Experimental rationale for the use of cell technologies for the correction of myometrial scar |
|
|
Pekarev O.G., Maiborodin I.V., Pozdnyakov I.M., Onoprienko N.V., Pekareva E.O., Anikeev A.A.
|
| No 9 (2022) |
Experimental technique for the transfer of pronuclear stage genetic material |
|
|
Sukhikh G.T., Kamaletdinov N.S., Nazarenko T.A., Martirosyan Y.O.
|
| No 4 (2020) |
Expert Council Resolution on Prevention and Treatment of Iron Deficiency Anemia in Pregnant Women |
|
|
- -.
|
| No 1 (2013) |
EXPRESSION OF APOPTOSIS-REGULATORY GENES IN DIFFERENT ENDOMETRIAL HYPERPLASIA TYPES AND ENDOMETRIOID CARCINOMA |
|
|
CHERNUKHA G.E., DUMANOVSKAYA M.R., BURMENSKAYA O.V., SHUBINA E.S., KOGAN E.A., TROFIMOV D.Y.
|
| No 7 (2023) |
Expression of ephrin receptor A1 on the membrane of epitheliocyte glands of the uterine mucosa in patients with endometrial cancer and endometriosis |
|
|
Muftaydinova S.K., Senina D.N., Litvinova V.V., Fayzullina N.M., Asaturova A.V., Buralkina N.A., Ovodenko D.L., Fayzullin L.Z., Chuprynin V.D.
|
| No 6 (2022) |
Expression of ephrin receptor A3 in glandular epithelial cells of uterine endometrium in patients with endometriosis and endometrial cancer |
|
|
Chuprynin V.D., Muftaydinova S.K., Senina D.N., Fayzullina N.M., Asaturova A.V., Buralkina N.A., Fayzullin L.Z., Ovodenko D.L., Kozachenko A.V.
|
| No 3 (2022) |
Expression of exosomal microRNA in high-grade ovarian cancer and ovarian endometriotic cysts |
|
|
Iurova M.V., Eldarov C.M., Bobrov M.Y., Khabas G.N., Pavlovich S.V.
|
| No 9 (2016) |
EXPRESSION OF MESENCHYMAL CELLULAR MARKERS IN THE ENDOMETRIUM IN HEALTH AND IN PROLIFERATIVE UTERINE DISEASES |
|
|
Anikina T.A., Sysoeva V.Y., Rubina K.A., Radzinsky V.E.
|
| No 9 (2013) |
EXPRESSION OF VIRAL ONCOGENES P16 AND KI67 AND VIRAL LOAD IN DIFFERENT TYPES OF UROGENITAL PAPILLOMAVIRUS INFECTION |
|
|
EVSTIGNEEVA N.P., KUZNETSOVA Y.N., BALBERT N.A., POTAPOVA A.L., MEDVEDEVA Y.A.
|
| No 11 (2019) |
Expression of vitamin d and its receptors in the villous chorion in missed miscarriage |
|
|
Bespalova O.N., Bakleicheva M.O., Kovaleva I.V., Tolibova G.K., Tral T.G., Kogan I.Y.
|
| No 2 (2024) |
Expression patterns of maternal and fetal tissue and exosomal microRNAs during pre-induction of labor (pilot study) |
|
|
Gaidarova A.R., Gusar V.A., Chagovets V.V., Kan N.E., Edilberg I.V., Baev O.R.
|
| No 2 (2012) |
EXPRESSIONS OF PERITONEAL MACROPHAGE SCAVENGER RECEPTORS IN EXTERNAL GENITAL ENDOMETRIOSIS |
|
|
ANTSIFEROVA Y.S., POSISEYEVA L.V., SOTNIKOVA N.Y., ELISEYEVA M.A.
|
| No 11 (2019) |
External cephalic version in cases of pelvic and transverse lie |
|
|
Semenova E.R.
|
| No 1 (2024) |
Extracellular vesicles derived from multipotent mesenchymal stromal cells: pathogenetic rationale for therapeutic use |
|
|
Martirosyan Y.O., Kadaeva A.I., Silachev D.N., Nazarenko T.A., Matveeva P.V.
|
| No 6 (2023) |
Extracellular vesicles in follicular fluid: clinical aspects and molecular biology |
|
|
Dovgan A.A., Akhmedova Z.F., Sysoeva A.P., Zingerenko B.V., Romanov E.A., Silachev D.N., Makarova N.P., Kalinina E.A.
|
| No 4-2 (2012) |
EXTRAGENITAL DISEASES AND THE SOCIAL STATUS OF WOMEN WITH SPONTANEOUS ABORTION |
|
|
MEDVEDEV B.I., VOROPAYEVA E.E., KAZACHKOV E.L., KAZACHKOVA E.A.
|
| No 1 (2015) |
Extragenital diseases as a cause of maternal death |
|
|
Shuvalova M.P., Frolova O.G., Grebennik T.K., Ratushnyak S.S., Guseva E.V.
|
| No 8 (2022) |
Extragenital endometriosis: diagnostic difficulties, modern treatment policy |
|
|
Yarmolinskaya M.I., Rusina E.I., Semenova V.O., Beganova A.K.
|
| No 10 (2018) |
Extragenital sexually transmitted infections: epidemiology, clinical presentations, diagnosis, and therapy |
|
|
Rakhmatulina M.R., Bolshenko N.V.
|
| No 6 (2022) |
Extramammary Paget’s disease |
|
|
Grekova Y.N., Zilberberg N.V., Kuznetsova E.I.
|
| No 9 (2020) |
Extraperitoneal cesarean section: the place of the operation in the world and in Russian obstetrics |
|
|
Krasnopolsky V.I., Melnikov A.P., Petrukhin V.A., Karamyan R.A.
|
| No 2 (2016) |
Extraplacental trophoblast structures: Study, structure, functions, properties, diagnostic and therapeutic value |
|
|
Prokopyuk V.Y.
|
| No 7 (2014) |
EXTREMELY PRETERM BIRTHS IN THE URAL FEDERAL DISTRICT: PROBLEMS AND PROSPECTS |
|
|
Bashmakova N.V., Malygina G.B., Litvinova A.M.
|
| No 5 (2019) |
Factors influencing the participation of women in cervical cancer screening programs |
|
|
Apolikhina I.A., Bashirova L.K., Gasanova G.F.
|
| No 5 (2024) |
Factors of energy metabolism in fetal growth restriction |
|
|
Kan N.E., Soldatova E.E., Tyutyunnik V.L., Borisova A.G., Tezikov Y.V., Lipatov I.S., Sadekova A.A., Alekseev A.A., Krasnyi A.M.
|
| No 9 (2023) |
Factors regulating placental angio/vasculogenesis in complications of pregnancy and childbirth |
|
|
Khomyakova E.V., Ziganshina M.M., Baev O.R.
|
| No 10 (2019) |
Fast track in gynecology: today’s realities |
|
|
Torubarov S.F., Dukhin A.O., Chmur E.N.
|
| No 6S (2019): Supplement |
FAST-TRACK KhIRURGIYa. STATsIONARNYY ETAP |
|
|
Lisovskaya E.V., Chuprynin V.D., Khil'kevich E.G., Mel'nikov M.V.
|
| No 5 (2022) |
Favorable maternal and perinatal outcomes of pregnancy in a COVID-19 patient with total lung damage |
|
|
Tezikov Y.V., Tezikova T.A., Lipatov I.S., Nechayeva M.V., Yakusheva A.O., Tyutyunnik V.L., Kan N.E.
|
| No 4 (2021) |
Favorable outcome of managing a pregnant woman with epidermolytic drug syndrome |
|
|
Tezikov Y.V., Tezikova T.A., Lipatov I.S., Shmakov R.G., Rakitina V.N., Mishina E.A.
|
| No 10 (2021) |
Favorable outcome of the extremely severe course of the new coronavirus infection COVID-19 during pregnancy in the presence of overall lung damage, acute myocarditis, and myocardial infarction |
|
|
Voropaeva E.E., Ishchenko L.S., Mikhailova S.A., Aleksandrov D.I., Khaidukova Y.V., Kazachkova E.A., Kazachkov E.L.
|
| No 4 (2022) |
Feasibility of delivery in patients receiving mesenchymal stromal cell-derived extracellular microvesicles during the previous caesarean section |
|
|
Sukhikh G.T., Pekareva E.O., Pekarev O.G., Silachev D.N., Maiborodin I.V., Baranov I.I., Pozdnyakov I.M., Bushueva N.S.
|
| No 6 (2018) |
Feasibility of objective assessment of the progress of preterm labor at different gestational ages |
|
|
Novikova V.A., Cherepakhin E.P., Glebova E.V., Nikonov M.A., Tomashevsky D.V.
|
| No 2 (2023) |
Feasibility of predicting fetal growth restriction, by identifying plasma biomarkers |
|
|
Izhoykina E.V., Trifonova E.A., Kutsenko I.G., Stepanov I.A., Gavrilenko M.M., Stepanov V.A.
|
| No 1 (2023) |
Feasibility of preimplantation genetic testing for aneuploidy in patients undergoing in vitro fertilization after conservative treatment of atypical hyperplasia and early endometrial cancer |
|
|
Krasnopolskaya K.V., Novikova O.V., Isakova K.M., Shostenko L.V., Rau D.I., Shishkina A.V.
|
| No 9 (2021) |
Feasibility of using long noncoding RNAs for predicting malignant transformation of cervical epithelium |
|
|
Levakov S.A., Obukhova E.A., Sheshukova N.A., Bol'shakova O.V., Shakhparonov M.I., Antipova N.V.
|
| No 10 (2021) |
Features of changes in the monocyte-macrophage cells in the placenta during preeclampsia |
|
|
Boris D.A., Tyutyunnik V.L., Kan N.E., Shchegolev A.I., Sinitsyna V.A., Sadekova A.A., Krasnyi A.M.
|
| No 1 (2013) |
FEATURES OF COGNITIVE PERFORMANCE IN POSTMENOPAUSAL WOMEN WITH ARTERIAL HYPERTENSION |
|
|
RUNIKHINA A.N., SHARASHKINA N.V., LARINA V.N., BART B.Y.
|
| No 10 (2019) |
Features of correction of the immune status in the therapy of infectious and inflammatory diseases of the reproductive system |
|
|
Khashukoeva A.Z., Ilyina I.Y., Agaeva Z.A., Agaeva M.I., Khlynova S.A.
|
| No 1 (2021) |
FEATURES OF ELECTIVE MEDICAL CARE PROVIDED TO PATIENTS WITH GYNECOLOGICAL DISEASES UNDER CONDITIONS OF A RISK FOR SPREADING THE NOVEL CORONAVIRUS INFECTION. EXPERIENCE OF THE URALS REGION |
|
|
MALGINA G.B., MIKHELSON A.A., MELKOZEROVA O.A., OKULOVA E.O., LAZUKINA M.V., LUKACH M.A., MINYAYLO E.M.
|
| No 9 (2021) |
Features of endometrial tissue metabolism of androgens: a modern view |
|
|
Gavisova A.A., Shevtsova M.A., Tskhovrebova L.T.
|
| No 1 (2020) |
Features of formation of the activity-dormancy cycle in fetuses with growth restriction and developmental delay |
|
|
Pavlova N.G., Dyusembinova S.D.
|
| No 10 (2018) |
Features of formation of the fetoplacental complex following transfer of fresh and vitrified embryos in in vitro fertilization programs |
|
|
Shumovskaya V.V., Putilova N.V., Mazurov D.O.
|
| No 9 (2015) |
Features of functional state of the mitochondrial apparatus in overweight and obese women in IVF programs |
|
|
Smolnikova V.Y., Gorshinova V.K., Volodina M.A., Tarasova N.V., Vysokikh M.Y., Kalinina E.A.
|
| No 6 (2022) |
Features of interaction of Toll-like receptors with virus infection of the reproductive tract as a predictor of chronic endometritis |
|
|
Ievleva K.D., Danusevich I.N., Suturina L.V.
|
| No 1 (2020) |
Features of karyotypes in married couples with reproductive functional problems in Kazakhstan |
|
|
Khoroshilova I.G., Lokshin V.N., Begimbaeva A.A., Sarsenbaeva Z.K., Valiev R.K., Rybina A.N., Karibaeva S.K., Kim A.V., Semenova N.Y.
|
| No 2 (2018) |
Features of medical care for gestational diabetes mellitus (in case of a specialized obstetric hospital) |
|
|
Radzinsky V.E., Papysheva O.V., Esipova L.N., Startseva N.M., Kotaish G.A.
|
| No 6 (2020) |
Features of micronutrient preparation for pregnancy in women with polycystic ovary syndrome |
|
|
Kuznetsova I.V., Gavrilova E.A.
|
| No 3 (2022) |
Features of modern obstetrics |
|
|
Serov V.N., Nesterova L.A.
|
| No 11 (2022) |
Features of neurogenesis in fetal growth restriction |
|
|
Kan N.E., Leonova A.A., Tyutyunnik V.L., Khachatryan Z.V.
|
| No 12 (2013) |
FEATURES OF REPRODUCTIVE BEHAVIOR OF YOUNG PEOPLE |
|
|
DIKKE G.B., EROFEEVA L.V.
|
| No 11 (2017) |
Features of reproductive function realization in HIV-infected women |
|
|
Selimova F.N., Perminova S.G., Mityurina E.V., Kozyrina N.V.
|
| No 10 (2017) |
Features of reproductive function realization in women with infertility and HIV infection in assisted reproductive technology programs |
|
|
Mityurina E.V., Perminova S.G., Selimova F.N., Kozyrina N.V., Abubakirov A.N.
|
| No 12 (2019) |
Features of serum lipidome in pregnant women with fetal macrosomia and a concurrence of macrosomia with gestational diabetes mellitus |
|
|
Odinokova V.A., Chagovets V.V., Shmakov R.G., Starodubtseva N.L., Salimova D.F., Kononikhin A.S., Frankevich V.E.
|
| No 6 (2017) |
FEATURES OF SOME VASOACTIVE HORMONES AND VASCULAR FACTORS IN WOMEN WITH METABOLIC SYNDROME AND THEIR INFLUENCE ON THE DEVELOPMENT OF OBSTETRIC COMPLICATIONS |
|
|
Palieva N.V., Botasheva T.L., Linde V.A., Avrutskaya V.V., Zheleznyakova E.V.
|
| No 5 (2019) |
Features of the cervical canal microbiota in prenatal amniorrhea and full-term pregnancy |
|
|
Kaganova M.A., Spiridonova N.V., Kazakova A.V., Devyatova O.O., Galkina D.A., Golovina O.N.
|
| No 12 (2017) |
Features of the composition of peripheral blood lymphocyte subpopulations with cytotoxic, killer, and regulatory functions in women with recurrent implantation failures in ART programs |
|
|
Amyan T.S., Krechetova L.V., Perminova S.G., Vtorushina V.V.
|
| No 11 (2016) |
FEATURES OF THE ENDOTHELIAL FUNCTIONAL STATE AND THE FEASIBILITY OF ITS CORRECTION IN PREMATURE OVARIAN FAILURE |
|
|
Pozdnyakova A.A., Sharashkina N.V., Ivanets T.Y., Butareva L.B., Runikhina N.K., Marchenko L.A.
|
| No 9 (2018) |
Features of the expression of the immunohistochemical markers P16 and KI67 in women with chronic cervicitis associated with bacterial and viral infections |
|
|
Bokach O.M., Niauri D.A., Tishkov A.V., Selkov S.A.
|
| No 4 (2018) |
Features of the myometrial status during cesarean section with regard to amniorrhea and birth activity: A clinical and morphological study |
|
|
Prikhodko A.M., Baev O.R., Karapetyan A.O., Demura T.A., Kogan E.A.
|
| No 8 (2019) |
FEATURES OF THE PROFILE OF PROTEINS SECRETED BY CELLS FROM THE ENDOMETRIOID FOCI AND EUTOPIC ENDOMETRIUM IN WOMEN WITH EXTERNAL GENITAL ENDOMETRIOSIS IN IN VITRO CULTURE |
|
|
PavlovichStanislav V.V., Krechetova L.V., Vtorushina V.V., Vanko L.V., Yushina M.N., Savilova A.M., MakiyanZograb N.N., Yarotskaya E.L., Khilkevich E.G., Chuprynin V.D., Sykhikh G.T.
|
| No 6 (2011) |
FEMALE COUNSELING AS AN IMPORTANT TOOL WHEN INDIVIDUALLY CHOOSING A CONTRACEPTIVE METHOD |
|
|
ALESINA I.L.
|
| No 3 (2021) |
Female genital microbiota: health, pathology, ways of correction |
|
|
Punchenko O.E., Bereznitskaya E.A., Ermolenko E.I.
|
| No 3 (2009) |
Female genital prolapse: etiology and pathogenesis |
|
|
Bakhaev V.V., Gorin V.S., Bakhayev V.V., Gorin V.S.
|
| No 8 (2024) |
Female intimate hygiene: a differentiated approach in an age-specific perspective |
|
|
Stenyaeva N.N., Sattarova V.V., Pashkevich K.I., Streltsova K.I., Khritinin D.F., Stenyaev E.Y.
|
| No 3 (2014) |
FEMALE LIBIDO PROBLEMS AND HORMONAL CONTRACEPTION |
|
|
FEDOROVA A.I.
|
| No 9 (2013) |
FEMALE REPRODUCTIVE ORGAN CANCER: MORBIDITY TRENDS IN THE PRIMORYE TERRITORY (1992-2011) |
|
|
PISAREVA L.F., BOYARKINA A.P., ODINTSOVA I.N., GURINA L.I., VOLKOV M.V.
|
| No 3 (2014) |
FEMALE REPRODUCTIVE SYSTEM AGING: FROM THEORY TO CLINICAL PRACTICE PART 1. THE ENDOCRINE AND CLINICAL CHARACTERISTICS OF FEMALE REPRODUCTIVE SYSTEM AGING STAGES |
|
|
Yureneva S.V., Ilyina L.M., Smetnik V.P.
|
| No 4 (2014) |
Female reproductive system aging: From theory to clinical practice. Part 2. Role of hormone therapy in solving the problems of transition stage and early postmenopause |
|
|
Yureneva S.V., Ilyina L.M.
|
| No 4 (2010) |
Ferric(III)-hydroxide saccharose complex (venofer): experience of its use in obstetric and pediatric gynecological practice |
|
|
Adamyan L.V., Smol'nova T.Y., Sibirskaya E.V., Adamyan L.V., Smolnova T.Y., Sibirskaya Y.V.
|
| No 7 (2014) |
FERTILITY FOLLOWING DISCONTINUATION OF HORMONAL CONTRACEPTION |
|
|
Tarasova M.A., Shapovalova K.A.
|
| No 11 (2021) |
Fertility outcomes in women after therapy for non-Hodgkin lymphoma |
|
|
Dmitrieva I.Y., Nazarenko T.A., Burduli A.G., Polushkina E.S., Khokhlova S.V.
|
| No 4 (2020) |
Fertility preservation in patients diagnosed with cancer during pregnanc |
|
|
Kirillova A.O., Bunyaeva E.S., Koval’skaya E.V., Kamaletdinov N.S., Khabas G.N., Farmakovskaya M.D., Sirotkina E.A., Mishieva N.G., Nazarenko T.A., Abubakirov A.N.
|
| No 4 (2020) |
Fertility preservation in patients with primary brain tumors |
|
|
Ladimirova I.V., Kalinina E.A., Nazarenko T.A., Astafyeva L.I., Sharipov O.I., Kalinin P.L.
|
| No 1 (2022) |
Fertility preservation in women with placenta accreta spectrum undergoing organsparing surgery |
|
|
Mikheeva A.A., Shmakov R.G., Rogachevskiy O.V., Yarygina T.A., Nizyaeva N.V., Amiraslanov E.Y.
|
| No 2 (2012) |
FERTILITY RECOVERY IN WOMEN WITH GENITAL ENDOMETRIOSIS |
|
|
KUZNETSOVA I.V., KHOVRINA E.A., KIRPIKOV A.S.
|
| No 3 (2021) |
Fetal adaptation to cardiotocography as a criterion of fetal condition |
|
|
Loginov V.V., Davydov D.G., Prikhod'ko A.M., Baev O.R., Degtyarev D.N.
|
| No 1 (2021) |
FETAL BRADYARRYTHMIA IN OBSTETRIC PRACTICE: DIAGNOSIS, POSSIBILITIES FOR THERAPEUTIC APPROACHES, AND PREVENTION |
|
|
POTAPOVA A.A., TIMOSHINA I.V., KHODZHAEVA Z.S., BOCKERIA E.L.
|
| No 6 (2023) |
Fetal cardiotocography in childbirth |
|
|
Istomina N.G., Baranov A.N., Dolidze M.Y.
|
| No 4 (2014) |
Fetal congenital diaphragmatic hernia: ultrasound diagnosis possibilities and prediction of postnatal outcome |
|
|
Demidov V.N., Mashinets N.V., Podurovskaya U.L., Burov A.A.
|
| No 2 (2016) |
Fetal diaphragmatic hernia: Diagnosis, treatment, postnatal outcomes |
|
|
Mashinets N.V.
|
| No 6 (2018) |
Fetal growth restriction and markers for mitochondrial dysfunction |
|
|
Vishnyakova P.A., Sukhanova I.A., Mikaelyan A.G., Bulatova Y.S., Pyataeva S.V., Balashov I.S., Borovikov P.I., Tetruashvili N.K., Vyssokikh M.Y.
|
| No 8 (2024) |
Fetal growth restriction in gestational diabetes mellitus: from pathogenesis to management tactics |
|
|
Ignatko I.V., Alieva F.N., Churganova A.A., Rodionova A.M., Romanova E.M., Usman Yz Y., Anokhina V.M., Cherkashina A.V.
|
| No 1 (2024) |
Fetal growth restriction in the rare co-occurrence of chromosomal and monogenic diseases |
|
|
Bolshakova A.S., Barkov I.Y., Frankevich N.A., Yarygina T.A., Shmakov R.G.
|
| No 12 (2020) |
Fetal growth restriction (retardation): everything the practitioner should know |
|
|
Yarygina T.A., Gus A.I.
|
| No 3 (2024) |
Fetal growth retardation as a predictor of health during the future life |
|
|
Gumeniuk E.G., Ivshin A.A., Svetova K.S.
|
| No 8 (2022) |
Fetal growth retardation in the context of fetal programming |
|
|
Soldatova E.E., Kan N.E., Tyutyunnik V.L., Volochaeva M.V.
|
| No 5 (2011) |
FETAL GROWTH RETARDATION: DIAGNOSIS AND AN OPTIMAL DELIVERY METHOD |
|
|
PALADI G., ILIADI-TULBURE K., TABUIKA U.G.
|
| No 10 (2020) |
Fetal lymphangiomas of various locations. The Center’s 14-year experience |
|
|
Mashinets N.V., Demidov V.N., Dorofeeva E.I., Podurovskaya Y.L., Panin A.P., Nikiforov D.V., Filippova E.A., Kulabukhova E.A.
|
| No 2 (2012) |
FETAL MACERATION |
|
|
PAVLOV K.A., DUBOVA E.A., BURDULI G.M., TALALAYEV A.G., SHCHEGOLEV A.I.
|
| No 1 (2018) |
FETAL MACROSOMIA: PREDICTION, PREVENTION, AND TACTICS FOR MANAGEMENT OF PREGNANCY AND DELIVERY |
|
|
Odinokova V.A., Shmakov R.G., Chagovec V.V.
|
| No 11 (2015) |
FETAL MECONIUM PERITONITIS: ULTRASOUND DIAGNOSIS AND OUTCOMES |
|
|
Mashinets N.V., Demidov V.N.
|
| No 11 (2018) |
Fetal mosaicism as a cause of false-negative noninvasive prenatal DNA screening for chromosome 21 aneuploidies |
|
|
Shubina J., Barkov I.Y., Stupko O.K., Kuznetsova M.V., Krasheninnikova R.V., Kim L.V., Tetruashvili N.K., Goltsov A.Y., Kochetkova T.O., Mukosey I.S., Karetnikova N.A., Bakharev V.A., Trofimov D.Y.
|
| No 3 (2018) |
Fetal programming |
|
|
Dzhobava E.M.
|
| No 2 (2023) |
Fetal sacrococcygeal teratoma: new about an old problem |
|
|
Kadyrberdieva F.Z., Syrkashev E.M., Kostyukov K.V., Shmakov R.G.
|
| No 9 (2020) |
Fetal sex in the development of gestational diabetes mellitus and endothelial dysfunction |
|
|
Botasheva T.L., Palieva N.V., Khloponina A.V., Vasiljeva V.V., Zheleznyakova E.V., Zavodnov O.P., Gudz E.B.
|
| No 4 (2009) |
Fetal traumatic damages at cesarean delivery and measures of their prevention |
|
|
Chernukha E.A., Komissarova L.M., Anan'ev E.V., Chernukha Y.A., Komissarova L.M., Ananyev Y.V.
|
| No 10 (2013) |
FETO-FETAL TRANSFUSION SYNDROME. FETOSCOPIC LASER COAGULATION OF ANASTOMOSES |
|
|
BUGERENKO A.E., KURTSER M.A., SICHINAVA L.G., SUKHANOVA D.I.
|
| No 6 (2010) |
FETOPLACENTAL ANGIOGENESIS DURING NORMAL PREGNANCY: A ROLE OF PLACENTAL GROWTH FACTOR AND ANGIOPOIETINS |
|
|
PAVLOV K.A., DUBOVA E.A., ShchEGOLEV A.I., Pavlov K.A., Dubova Y.A., Shchegolev A.I.
|
| No 3 (2011) |
FETOPLACENTAL ANGIOGENESIS DURING NORMAL PREGNANCY: A ROLE OF VASCULAR ENDOTHELIAL GROWTH FACTOR |
|
|
PAVLOV K.A., DUBOVA E.A., SHCHEGOLEV A.I.
|
| No 9 (2020) |
Fibrin monomer and D-dimer in infertile women undergoing assisted reproductive technology |
|
|
Godzoeva A.O., Zazerskaya I.E., Vlasov V.S., Vavilova T.V., Gorelova I.V., Kustarov V.N., Zhambalova T.V.
|
| No 12 (2018) |
Fifty years of rhesus-immunization immunoprophylaxis: on guard of perinatal morbidity and infant mortality |
|
|
Savelyeva G.M., Kurtser M.A., Sichinava L.G., Konoplyannikov A.G., Latyshkevich O.A., Songolova E.N.
|
| No 4 (2020) |
First experience of autologous platelet rich plasma injection into the endometrium in patients with uterine factor infertility |
|
|
Efendieva Z.N., Apolikhina I.A., Kalinina E.A., Fedorova T.A., Bakuridze E.M., Belousov D.M., Fathudinov T.K., Sukhikh G.T.
|
| No 7 (2019) |
First experience with temporal aortic balloon occlusion in Russian obstetric practice |
|
|
Malgina G.B., Kayumova A.V., Kardapoltsev L.V., Kochmashev I.V., Klimusheva N.F., Erofeev E.N., Zyryanov M.N., Polyanin D.V., Makarov R.A.
|
| No 8 (2018) |
FIRST TRIMESTER PREDICTION OF PREECLAMPSIA BASED ON MATERNAL FACTORS, BIOMARKERS AND 3D POWER DOPPLER OF PLACENTAL BED VASCULARIZATION |
|
|
Kholin A.M., Muminova K.T., Mukhamedovich N.T., Khodzhaeva Z.S., Gus A.I.
|
| No 5 (2021) |
First-line hormone treatment for endometriosis |
|
|
Tikhomirov A.L.
|
| No 8 (2017) |
First-trimester prediction of preeclampsia: Validation of screening algorithms in a Russian population |
|
|
Kholin A.M., Muminova K.T., Balashov I.S., Khodzhaeva Z.S., Borovikov P.I., Ivanets T.Y., Gus A.I.
|
| No 9 (2019) |
Five-year use of robotic surgery in operative gynecology: summary and prospects |
|
|
Krasnopolsky V.I., Popov A.A., Krasnopolskaya K.V., Fedorov A.A.
|
| No 8 (2011) |
FLUORESCENCE DIAGNOSIS AND PHOTODYNAMIC THERAPY FOR VULVAR CONDYLOMATA ACUMINATA |
|
|
DENISOVA E.D., APOLIKHINA I.A., BULGAKOVA N.N.
|
| No 3 (2010) |
Fluorescence diagnosis and photodynamic therapy: the possibilities of their use in lower genital tract diseases |
|
|
Denisova E.D., Apolikhina I.A., Bulgakova N.N., Denisova E.D., Apolikhina I.A., Bulgakova N.N.
|
| No 1 (2019) |
Fluorescence hysteroresectoscopy in the clarifying diagnosis of early endometrial cancer |
|
|
Pronin S.M., Matsneva I.A., Maltsagov M.R.
|
| No 3 (2016) |
FMR1 GENE POLYMORPHISM IN POLYCYSTIC OVARY SYNDROME |
|
|
Tabeeva G.I., Nemova Y.I., Naidukova A.A., Kuznetsova E.B., Zaletaev D.B., Chernukha G.E.
|
| No 6 (2014) |
FOLIC ACID DOSAGE BEFORE, DURING, AND AFTER PREGNANCY: TO DOT THE I'S AND CROSS THE T'S |
|
|
GROMOVA O.A., LIMANOVA O.A., TORSHIN I.Y., KERIMKULOVA N.V., RUDAKOVA K.V.
|
| No 12 (2022) |
Follitropin delta in IVF/ICSI programs |
|
|
Krasnopolskaya K.V., Isakova K.M., Ershova I.Y., Shostenko L.V., Shishkina A.V.
|
| 1201 - 1400 of 3968 Items |
<< < 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 > >> |
